EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $98.9670, but opened at $94.81. EssilorLuxottica shares last traded at $94.86, with a volume of 3,601 shares changing hands.
Analysts Set New Price Targets
Several equities research analysts have issued reports on the company. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a report on Tuesday, May 12th. They issued a “hold” rating for the company. The Goldman Sachs Group lowered EssilorLuxottica from a “buy” rating to a “hold” rating in a research report on Tuesday, July 14th. Finally, Zacks Research cut EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research note on Tuesday, June 23rd. Two investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Report on EssilorLuxottica
EssilorLuxottica Price Performance
About EssilorLuxottica
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Recommended Stories
- Five stocks we like better than EssilorLuxottica
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
